Cellyan Biotechnology Co., Ltd

HKPD

$0.14

-3.29%

N/A-$0.00

Healthcare

Medical - Distribution

NASDAQ

Active Trading

Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and ...

Supply Chain of HKPD

Upstream

Foundry, packaging, memory, wafers, components, and input vendors.

Upstream

Global OTC Pharmaceutical Manufacturers (unnamed portfolio)

Logistics & Warehousing Service Providers (Hong Kong/Mainland China)

Customs Clearance & Compliance Service Partners

International Pharmaceutical Raw Material & API Suppliers

Global OTC Pharmaceutical Manufacturers (unnamed portfolio)

Suppliers of OTC drugs for cross-border procurement and distribution via V-Alliance; includes international and Chinese OTC drug makers

Logistics & Warehousing Service Providers (Hong Kong/Mainland China)

Freight forwarding, warehousing, and last-mile delivery partners for cross-border supply chain operations

Customs Clearance & Compliance Service Partners

Regulatory and customs brokerage services enabling cross-border OTC pharmaceutical imports into Mainland China

International Pharmaceutical Raw Material & API Suppliers

Suppliers to global OTC pharmaceutical manufacturers; indirect upstream of HKPD's procurement division

Downstream

Customers, distributors, OEMs, and channels that absorb output.

Downstream

Hangzhou Cainiao Supply Chain Management Co., Ltd. (CaiNiao)

Merchants on Chinese E-Commerce Platforms (Tmall Global, JD Worldwide, etc.)

Leading Chinese E-Commerce Platform (Undisclosed — partnership announced Feb 2025)

End Pharmacies & Healthcare Retailers in Mainland China

Hangzhou Cainiao Supply Chain Management Co., Ltd. (CaiNiao)

NYSE:BABA

Primary e-commerce platform logistics partner; engages HKPD's supply chain services for cross-border OTC pharmaceutical fulfillment. CaiNiao is the logistics arm of Alibaba Group. · 50.0%

Merchants on Chinese E-Commerce Platforms (Tmall Global, JD Worldwide, etc.)

OTC pharmaceutical merchants selling cross-border via Chinese platforms who use HKPD's supply chain and fulfillment services · 30.0%

Leading Chinese E-Commerce Platform (Undisclosed — partnership announced Feb 2025)

Unconfirmed

Strategic partnership to enhance cross-border logistics services; platform not named in public releases

End Pharmacies & Healthcare Retailers in Mainland China

Downstream recipients of OTC pharmaceuticals distributed via HKPD's cross-border supply chain; served indirectly through e-commerce platform merchants

Proxies

Public comparables and monitoring names used as representatives for the analysis.

Proxies

Alibaba Group Holding Limited

JD Logistics, Inc.

Best Inc.

ZTO Express (Cayman) Inc.

China National Accord Medicines Co., Ltd.

Alibaba Group Holding Limited

NYSE:BABA

Ultimate parent of CaiNiao, HKPD's largest customer. Alibaba ecosystem drives HKPD's cross-border OTC pharmaceutical e-commerce volumes.

JD Logistics, Inc.

HKEx:2618

Competing cross-border logistics and supply chain platform in China; provides a comparable publicly-listed proxy for supply chain services in the China e-commerce logistics space.

Best Inc.

NYSE:BEST

Supply chain management and logistics services provider in China; similar business model serving cross-border e-commerce, though not pharma-specific.

ZTO Express (Cayman) Inc.

NYSE:ZTO

Major Chinese express delivery and logistics company; relevant proxy for China cross-border logistics infrastructure.

China National Accord Medicines Co., Ltd.

SZSE:000028

Leading pharmaceutical distributor in China; proxy for the pharmaceutical distribution side of HKPD's operations.

Geographic

Region-level exposures that can distort the supply network.

Geographic

Hong Kong / Mainland China Cross-Border

Mainland China

Hangzhou Cainiao Supply Chain Management Co., Ltd.

Merchants on Chinese E-Commerce Platforms

Hong Kong / Mainland China Cross-Border

Regulatory & Policy

Hangzhou Cainiao Supply Chain Management Co., Ltd.NYSE:BABAPrimary customer — Alibaba Group logistics arm

Mainland China

E-Commerce Platform Dependency

Merchants on Chinese E-Commerce PlatformsIndirect end-customers via platform merchants

Concentration

Customer, supplier, or partner concentration exposures that can distort the supply network.

Customer

Critical

Heavy customer concentration on CaiNiao (Alibaba's logistics arm), estimated at ~50% of revenue. Loss of this relationship would materially impact operations.

Other

High

Revenue concentrated in only two business segments (Supply Chain Services and Procurement & Distribution), both tied to cross-border OTC pharmaceutical e-commerce. Limited diversification.

Other

Critical

Micro-cap public company (market cap ~$4M as of June 2026) with limited financial resources, declining revenue (-21% YoY), and Nasdaq bid-price deficiency notice received January 2026.

Revenue mix

How the target's revenue mix translates into supply-chain leverage and dependency.

Supply Chain Services (Joint Cross Border)

61.4%

$0.0B

Drives demand for logistics, warehousing, customs clearance partners. Relies on e-commerce platform logistics partners like CaiNiao as primary customers. Lower margin but higher volume service line.

Procurement and Distribution (V-Alliance)

38.6%

$0.0B

Drives demand for global OTC pharmaceutical manufacturers/suppliers. Requires strong supplier sourcing and regulatory compliance. Higher value-add per transaction.

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer